Skip to content

The additional effect of the respiratory rehabilitation to the COPD patient who did additional medical treatment of budesonide / formoterol at tiotropium

The additional effect of the respiratory rehabilitation to the COPD patient who did additional medical treatment of budesonide / formoterol at tiotropium - The additional effect of the respiratory rehabilitation to the COPD patient who did additional medical treatment of budesonide / formoterol at tiotropium

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011564
Enrollment
20
Registered
2013-09-01
Start date
2013-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

BUD/folmoterol ,Respiratory rehabilitation

Sponsors

Komaki City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (a) An outpatient aged 40 and over in the age at the time of agreement acquisition (b) The patient who has the condition of COPD and will have a smoking history equivalent to 10 or more pack year of patients (c) currently diagnosed as COPD from two years or more before (d) He is a ten or more CAT questionnaires patient at Visit1.

Exclusion criteria

Exclusion criteria: (a) The patient who has BUD/FM in preliminary medication (b) The patient who has received hospitalization or the whole body, inhalation steroid medicine medication, and medication of the antibiotic within one month before the examination (c) The patient who has received the domiciliary oxygen therapy periodically (d) A patient with the past of bronchial asthma (e) The patient who has the past of hypersensitivity in BUD/FM (f) The patient who has chronic diseases, such as a lung, the heart, the kidney, liver, and blood (g) The patient who has an anamnesis of adrenal cortical insufficiency (h) The patient who judged test inclusion to be improper by an examination responsibility doctor's judgment

Design outcomes

Primary

MeasureTime frame
Exercise tolerability by 6-minute walk distance The amount of body activities by an active mass meter

Secondary

MeasureTime frame
Respiratory function Condition score (CAT)

Countries

Japan

Contacts

Public ContactSUSUMU IWATA

Komaki City Hospital Respiratory division

sin@komakihp.gr.jp0568764131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026